When overexpressing telomerase reverse transcriptase (telomerase catalytic subunit; TERT) in mouse models for either anti-tumor therapy or advanced age, their median survival time increased independently from the tumor incidence, indicating that telomere length contributes to survival during aging [17]. This evidence concerns the gene TERT and neoplasm.